
Sign up to save your podcasts
Or
In this episode, we cover a topic we've never touched on: Analysts, From a marketing standpoint, the use of analysts is not as understood as it should be.
When I ran my own software company, we found analysts extremely helpful, helping position us to prospective customers and finding partners. We merged with another company because one of the analysts recommended that we meet. And so, you never know what's going to happen through these relations with analysts.
In this episode, I speak with John Moore III, Managing Partner of specialist firm Chilmark Research, who pulls back the curtain on analysts' far-reaching impact shaping adoption for transformative health IT.
John goes into key dynamics technology suppliers must grasp working effectively with these selective gatekeepers. Beyond detailing how Chilmark delivers its perspectives and thought leadership to provider, payer, and life science clients, he spotlights areas ripe for innovator impact – from addressing the elusive quest to demonstrate ROI to leveraging advances in AI and real-world evidence.
Additional topics covered include:
I think you will enjoy the conversation. I did! And I learned a lot too.
5
66 ratings
In this episode, we cover a topic we've never touched on: Analysts, From a marketing standpoint, the use of analysts is not as understood as it should be.
When I ran my own software company, we found analysts extremely helpful, helping position us to prospective customers and finding partners. We merged with another company because one of the analysts recommended that we meet. And so, you never know what's going to happen through these relations with analysts.
In this episode, I speak with John Moore III, Managing Partner of specialist firm Chilmark Research, who pulls back the curtain on analysts' far-reaching impact shaping adoption for transformative health IT.
John goes into key dynamics technology suppliers must grasp working effectively with these selective gatekeepers. Beyond detailing how Chilmark delivers its perspectives and thought leadership to provider, payer, and life science clients, he spotlights areas ripe for innovator impact – from addressing the elusive quest to demonstrate ROI to leveraging advances in AI and real-world evidence.
Additional topics covered include:
I think you will enjoy the conversation. I did! And I learned a lot too.
43,343 Listeners